Brooks Automation

Brooks Automation was founded in 1978 and is based in Chelmsford, Massachusetts. The company is a provider of automation, vacuum and instrumentation equipment for multiple markets, including semiconductor manufacturing, technology device manufacturing, and life sciences.

Brooks Automation
Public
Traded as
ISINUS1143401024 
IndustrySemiconductor Equipment & Materials
Founded1978 (1978)
Headquarters,
Key people
  • Stephen S. Schwartz (CEO)[1]
  • David Jarzynka (SVP and GM Semiconductor Group)
  • Lindon G. Robertson ( Chief Financial Officer)
Revenue$ 631.56M(Sep 30, 2018)[2]
Number of employees
1471 (Dec 31, 2013)
Websitewww.brooks.com

History

Brooks Automation was set up in 1978 and incorporated in 1994.

In 2002, Brooks Automation, Inc. completed the acquisition of Intelligent Automation Systems, Inc. of Cambridge, Massachusetts, a custom automation company with technology and products for the semiconductor, photonics and life sciences industries.[3]

Brooks Automation acquired the Celigo automated Cell Cytometer product line from Cyntellect, Inc in 2011. The same year, Brooks acquired Nexus Biosystems, which produced compound and sample management systems.[1] The following year the company acquired intangible assets from Intevac, Inc. and acquired Crossing Automation Inc.[4][5]

In October 2012, Brooks Automation entered into an agreement to acquire Crossing Automation Inc.[6]

In April 2014, Brooks Automation entered into an agreement to sell its Granville-Phillips division to MKS Instruments.[7]

Brooks closed the sale of Granville-Phillips to MKS Instruments on May 30, 2014.[8]

In 2017 Brooks acquired 4titude, a maker of scientific tools and consumables, while in 2018, Brooks acquired GENEWIZ, a genomics services provider as part of their life sciences division's expansion.[1]

Business

Brooks Automation operates in three segments: Brooks Product Solutions, Brooks Global Services, and Brooks Life Science Systems.[9][10]

Brooks Automation provides mainly four kinds: semiconductor automation and life science systems equipment, gas analysis and vacuum measurement, cryopumps, cryochillers and compressors, asset tracking equipment. The company features in developing and building the handling system and related technology. Automation products are used to support both atmospheric and vacuum based processes while the company's focus remains on improving performance and productivity. The company provides vacuum pumps and instrumentation to maintain pressure consistency of the known process gas. The Brooks Life Science Systems provides automated sample management systems and equipment, such as automated blood fractionation equipment, cellular imaging, and consumables parts.[4]

Research and development

  • 2013.7, Brooks Automation announced that it had signed a definitive agreement to acquire the assets and business of Matrical, Inc.($10 million) to expand the Brooks Life Science Systems business. Matrical focuses on biological sample preparation, management, and storage solutions.[11]
  • 2012.4, Brooks Automation announced the Polycold Systems XC Cryochiller (a multi-purpose cooler) product line and set a new standard in the industry. With the new production line put into use in vacuum and thermal management applications, it would greatly increase water vapor pumping speed and decrease the operating costs.[12]
  • 2012.1, Brooks Automation announced that it had acquired the Celigo Cell Cytometer product line from Cyntellect Inc. Celigo had an advantage in cell imaging systems based on its unique combination of high-throughput, ease-of-use, and affordability.[5]

Awards

Brooks Automation won the R&D 100 award (100 most technologically significant new products introduced) by R&D Magazine for its Model 830 Vacuum Quality Monitor (VQMTM). VQMTM was used to determine gas composition with an electrostatic autoresonant ion trap.[13]

gollark: Oh no.
gollark: --radio_connect
gollark: --radio_connect
gollark: --radio_connect
gollark: ++magic py if bot.voice: await bot.voice.disconnect()

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.